President and CEO Morimoto will appear on the radio program 'Murakami Shingo-kun and Keizai-kun' broadcast on May 5th (Sat.)

FRONTEO is pleased to announce that President and CEO Masahiro Morimoto will be appearing on the radio program "Murakami Shingo-kun and Keizai-kun" on Nippon Cultural Broadcasting (frequency: FM2025/AM5MHz) on Saturday, May 17, 91.6.
With the theme of "How to make new medicines," we will talk about the challenges facing drug discovery in Japan and how FRONTEO's in-house developed AI "KIBIT" can increase the chances of success in drug discovery.

Program name: Shingo Murakami and the Economy Broadcast date: Saturday, May 2025, 5 17:9-00:10 Program website: Special feature on the latest "drug discovery technology" using AI! "Murakami Shingo-kun and Economics-kun" https://www.joqr.co.jp/qr/article/152253/

Please refer to the URL below for how to listen to Nippon Cultural Broadcasting. https://www.joqr.co.jp/howto/

About FRONTEO's AI drug discovery support service "Drug Discovery AI Factory (DDAIF)" https://lifescience.fronteo.com/products/drug-discovery-ai-factory/ "FRONTEO Drug Discovery AI Factory (DDAIF)" is an AI drug discovery support service that combines the knowledge of FRONTEO's drug discovery researchers and AI engineers with "KIBIT" (patented in Japan, the US and Europe), an AI specialized in natural language processing. It strongly supports researchers' decision-making in drug development by analyzing disease-related gene networks and building hypotheses about target candidates. This service has already been introduced at several major pharmaceutical companies and is accumulating a proven track record.

[Reference: Co-creation project with pharmaceutical companies]
- FRONTEO and Chugai Pharmaceutical Launch Co-Creation Project for Target Discovery Using Drug Discovery AI Factory
- EA Pharma and FRONTEO launch co-creation project to explore drug discovery targets using AI
- FRONTEO and Eisai Launch Co-Creation Project for Target Discovery Using Drug Discovery AI Factory
- FRONTEO and Maruishi Pharmaceutical Launch Co-Creation Project for Biomarker Discovery Using Drug Discovery AI Factory
- FRONTEO and UBE launch co-creation project on drug repositioning using Drug Discovery AI Factory

[Reference: Joint research projects with academia]
- FRONTEO and Tokyo University of Science begin joint research to identify new drug discovery targets using the "Drug Discovery AI Factory"
- FRONTEO and Kumamoto University begin joint research to discover new cancer treatments using Drug Discovery AI Factory